CH475997A - Verfahren zur Herstellung einer antibiotisch wirksamen Substanz - Google Patents
Verfahren zur Herstellung einer antibiotisch wirksamen SubstanzInfo
- Publication number
- CH475997A CH475997A CH1683365A CH1683365A CH475997A CH 475997 A CH475997 A CH 475997A CH 1683365 A CH1683365 A CH 1683365A CH 1683365 A CH1683365 A CH 1683365A CH 475997 A CH475997 A CH 475997A
- Authority
- CH
- Switzerland
- Prior art keywords
- production
- antibiotic substance
- antibiotic
- substance
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/8215—Microorganisms
- Y10S435/822—Microorganisms using bacteria or actinomycetales
- Y10S435/886—Streptomyces
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Peptides Or Proteins (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US416599A US3361742A (en) | 1964-12-07 | 1964-12-07 | 5-oxo-1h-pyrrolo-[2, 1-c][1, 4]-benzodiazepin-2-crylamides |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CH475997A true CH475997A (de) | 1969-07-31 |
Family
ID=23650586
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CH1683365A CH475997A (de) | 1964-12-07 | 1965-12-07 | Verfahren zur Herstellung einer antibiotisch wirksamen Substanz |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US3361742A (de) |
| AT (1) | AT269350B (de) |
| BE (1) | BE673376A (de) |
| BR (1) | BR6575537D0 (de) |
| CH (1) | CH475997A (de) |
| DE (1) | DE1467872A1 (de) |
| ES (1) | ES320436A1 (de) |
| FR (1) | FR1553664A (de) |
| GB (1) | GB1092888A (de) |
| NL (1) | NL6515880A (de) |
| SE (1) | SE316136B (de) |
Families Citing this family (46)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3523941A (en) * | 1967-03-06 | 1970-08-11 | Hoffmann La Roche | Benzodiazepine compounds and process for their preparation |
| US3524849A (en) * | 1967-10-27 | 1970-08-18 | Hoffmann La Roche | Process for the preparation of pyrrolo-benzodiazepine acrylamides and intermediates useful therein |
| DE1965304A1 (de) * | 1968-12-30 | 1970-07-23 | Fujisawa Pharmaceutical Co | Benzdiazepinon-Verbindungen und Verfahren zu ihrer Herstellung |
| JPS5279082A (en) * | 1975-12-25 | 1977-07-02 | Green Cross Corp:The | Preparation of anti-tumor compound |
| JPS585916B2 (ja) | 1977-12-27 | 1983-02-02 | 株式会社ミドリ十字 | 新規ベンゾジアゼピン系化合物 |
| CA1214774A (en) * | 1983-02-10 | 1986-12-02 | Yusei Shiraga | Benzodiazepine derivative |
| AUPO470197A0 (en) * | 1997-01-21 | 1997-02-13 | Attfield, Paul Victor | Fluorescent dyes from microorganisms |
| ES2623057T3 (es) | 2010-04-15 | 2017-07-10 | Medimmune Limited | Pirrolobenzodiazepinas usadas para tratar enfermedades proliferativas |
| KR101772354B1 (ko) | 2010-04-15 | 2017-08-28 | 시애틀 지네틱스, 인크. | 표적화된 피롤로벤조디아제핀 접합체 |
| WO2013041606A1 (en) | 2011-09-20 | 2013-03-28 | Spirogen Sàrl | Pyrrolobenzodiazepines as unsymmetrical dimeric pbd compounds for inclusion in targeted conjugates |
| BR112014008888A2 (pt) | 2011-10-14 | 2017-04-18 | Seattle Genetics Inc | pirrolobenzodiazepinas |
| US9526798B2 (en) | 2011-10-14 | 2016-12-27 | Seattle Genetics, Inc. | Pyrrolobenzodiazepines and targeted conjugates |
| MX358757B (es) | 2011-10-14 | 2018-09-03 | Seattle Genetics Inc | Pirrolobenzodiazepinas y conjugados dirigidos. |
| US9388187B2 (en) | 2011-10-14 | 2016-07-12 | Medimmune Limited | Pyrrolobenzodiazepines |
| KR101645905B1 (ko) | 2012-10-12 | 2016-08-04 | 스피로즌 살 | 피롤로벤조디아제핀 및 그의 컨주게이트 |
| MX364328B (es) | 2012-10-12 | 2019-04-23 | Medimmune Ltd | Conjugados del anticuerpo pirrolobenzodiazepina. |
| ES2680153T3 (es) | 2012-10-12 | 2018-09-04 | Adc Therapeutics Sa | Conjugados de anticuerpos anti-PSMA-pirrolobenzodiazepinas |
| PL2906251T3 (pl) | 2012-10-12 | 2018-02-28 | Adc Therapeutics Sa | Koniugaty pirolobenzodiazepina-przeciwciało anty-CD22 |
| WO2014057117A1 (en) | 2012-10-12 | 2014-04-17 | Adc Therapeutics Sàrl | Pyrrolobenzodiazepine-antibody conjugates |
| WO2014057120A1 (en) | 2012-10-12 | 2014-04-17 | Adc Therapeutics Sàrl | Pyrrolobenzodiazepine-antibody conjugates |
| AU2013328673B2 (en) | 2012-10-12 | 2017-07-13 | Medimmune Limited | Synthesis and intermediates of pyrrolobenzodiazepine derivatives for conjugation |
| HRP20181646T2 (hr) | 2012-10-12 | 2019-08-09 | Adc Therapeutics Sa | Konjugati pirolobenzodiazepin - anti-psma protutijela |
| HRP20190366T1 (hr) | 2012-10-12 | 2019-04-19 | Medimmune Limited | Pirolobenzodiazepini i njihovi konjugati |
| US9950078B2 (en) | 2013-10-11 | 2018-04-24 | Medimmune Limited | Pyrrolobenzodiazepine-antibody conjugates |
| GB201317982D0 (en) | 2013-10-11 | 2013-11-27 | Spirogen Sarl | Pyrrolobenzodiazepines and conjugates thereof |
| US10010624B2 (en) | 2013-10-11 | 2018-07-03 | Medimmune Limited | Pyrrolobenzodiazepine-antibody conjugates |
| GB201317981D0 (en) | 2013-10-11 | 2013-11-27 | Spirogen Sarl | Pyrrolobenzodiazepines and conjugates thereof |
| EP3054986B1 (de) | 2013-10-11 | 2019-03-20 | Medimmune Limited | Pyrrolobenzodiazepin-antikörper-konjugate |
| GB201416112D0 (en) | 2014-09-12 | 2014-10-29 | Medimmune Ltd | Pyrrolobenzodiazepines and conjugates thereof |
| US10780096B2 (en) | 2014-11-25 | 2020-09-22 | Adc Therapeutics Sa | Pyrrolobenzodiazepine-antibody conjugates |
| GB201506411D0 (en) | 2015-04-15 | 2015-05-27 | Bergenbio As | Humanized anti-axl antibodies |
| GB201506402D0 (en) | 2015-04-15 | 2015-05-27 | Berkel Patricius H C Van And Howard Philip W | Site-specific antibody-drug conjugates |
| GB201601431D0 (en) | 2016-01-26 | 2016-03-09 | Medimmune Ltd | Pyrrolobenzodiazepines |
| GB201602356D0 (en) | 2016-02-10 | 2016-03-23 | Medimmune Ltd | Pyrrolobenzodiazepine Conjugates |
| GB201602359D0 (en) | 2016-02-10 | 2016-03-23 | Medimmune Ltd | Pyrrolobenzodiazepine Conjugates |
| GB201607478D0 (en) | 2016-04-29 | 2016-06-15 | Medimmune Ltd | Pyrrolobenzodiazepine Conjugates |
| GB201617466D0 (en) | 2016-10-14 | 2016-11-30 | Medimmune Ltd | Pyrrolobenzodiazepine conjugates |
| UA125198C2 (uk) | 2017-02-08 | 2022-01-26 | Ейдісі Терапьютікс Са | Кон'югати піролобензодіазепін-антитіло |
| GB201702031D0 (en) | 2017-02-08 | 2017-03-22 | Medlmmune Ltd | Pyrrolobenzodiazepine-antibody conjugates |
| SI3612537T1 (sl) | 2017-04-18 | 2022-10-28 | Medimmune Limited | Konjugati pirolobenzodiazepina |
| WO2018193102A1 (en) | 2017-04-20 | 2018-10-25 | Adc Therapeutics Sa | Combination therapy with an anti-axl antibody-drug conjugate |
| JP7145891B2 (ja) | 2017-06-14 | 2022-10-03 | アーデーセー セラピューティクス ソシエテ アノニム | 抗ｃｄ１９ ａｄｃを投与するための投与レジメ |
| BR112020003003A2 (pt) | 2017-08-18 | 2020-08-11 | Medimmune Limited | conjugados de pirrolobenzodiazepina |
| GB201803342D0 (en) | 2018-03-01 | 2018-04-18 | Medimmune Ltd | Methods |
| GB201806022D0 (en) | 2018-04-12 | 2018-05-30 | Medimmune Ltd | Pyrrolobenzodiazepines and conjugates thereof |
| MX2021010477A (es) | 2019-03-15 | 2021-10-01 | Medimmune Ltd | Dimeros de azetidobenzodiazepina y conjugados que los comprenden para uso en el tratamiento de cancer. |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3247187A (en) * | 1963-07-10 | 1966-04-19 | Hoffmann La Roche | Oxidation of 1, 4-benzodiazepines to 1, 4-benzodiazepin-2-ones |
-
1964
- 1964-12-07 US US416599A patent/US3361742A/en not_active Expired - Lifetime
-
1965
- 1965-12-03 FR FR1553664D patent/FR1553664A/fr not_active Expired
- 1965-12-04 DE DE19651467872 patent/DE1467872A1/de active Pending
- 1965-12-06 AT AT1097465A patent/AT269350B/de active
- 1965-12-06 ES ES0320436A patent/ES320436A1/es not_active Expired
- 1965-12-06 GB GB51119/65A patent/GB1092888A/en not_active Expired
- 1965-12-07 NL NL6515880A patent/NL6515880A/xx unknown
- 1965-12-07 SE SE15830/65A patent/SE316136B/xx unknown
- 1965-12-07 BR BR175537/65A patent/BR6575537D0/pt unknown
- 1965-12-07 CH CH1683365A patent/CH475997A/de not_active IP Right Cessation
- 1965-12-07 BE BE673376D patent/BE673376A/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| FR1553664A (de) | 1969-01-17 |
| BR6575537D0 (pt) | 1973-09-06 |
| AT269350B (de) | 1969-03-10 |
| GB1092888A (en) | 1967-11-29 |
| NL6515880A (de) | 1966-06-08 |
| ES320436A1 (es) | 1966-05-16 |
| SE316136B (de) | 1969-10-20 |
| BE673376A (de) | 1966-04-01 |
| DE1467872A1 (de) | 1969-05-14 |
| US3361742A (en) | 1968-01-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CH475997A (de) | Verfahren zur Herstellung einer antibiotisch wirksamen Substanz | |
| CH490309A (de) | Verfahren zur Herstellung substituierter Biphenylessigsäuren | |
| CH478156A (de) | Verfahren zur Herstellung neuartiger Antibiotika | |
| AT275780B (de) | Verfahren zur Herstellung von Sinterkörpern | |
| CH479589A (de) | Verfahren zur Herstellung von Imidazolen | |
| CH473758A (de) | Verfahren zur Herstellung von Trimethylhexamethylendiamin | |
| CH480434A (de) | Verfahren zur Herstellung des Antibiotikums Kasugamycin | |
| AT266313B (de) | Verfahren zur Herstellung einer antikoagulierend wirkenden Substanz | |
| CH475923A (de) | Verfahren zur Herstellung homöoporöser Kohlenstoffkörper | |
| AT259762B (de) | Verfahren zur Herstellung eines Antibioticums | |
| CH454163A (de) | Verfahren zur Herstellung von Polyhalogenphenolen | |
| CH437345A (de) | Verfahren zur Herstellung von cyclischen Äthern | |
| CH454161A (de) | Verfahren zur Herstellung eledoisinwirksamer Undekapeptide | |
| AT260539B (de) | Verfahren zur Herstellung von Schwefel-Harz-Massen | |
| AT255880B (de) | Verfahren zur Herstellung einer Übergußmasse | |
| AT256808B (de) | Verfahren zur Herstellung von ɛ-Caprolactam | |
| CH461498A (de) | Verfahren zur Herstellung substituierter e-Caprolactame | |
| CH472427A (de) | Verfahren zur Herstellung von Antibiotika | |
| AT289090B (de) | Verfahren zur Herstellung von Rhodanverbindungen | |
| CH441355A (de) | Verfahren zur Herstellung von Antibiotika | |
| CH468365A (de) | Verfahren zur Herstellung von Testosteron-Derivaten | |
| AT261896B (de) | Verfahren zur Herstellung von Polyvinylalkoholderivaten | |
| AT266314B (de) | Verfahren zur Herstellung des neuen Antibiotikums Lincomycin B | |
| CH458392A (de) | Verfahren zur Herstellung von Merkaptalen | |
| AT255614B (de) | Verfahren zur Herstellung von Überzügen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PL | Patent ceased |